Plain-English translation of NCT06334952 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called transcranial direct current stimulation (tDCS)—a non-invasive procedure where mild electrical currents are applied to your scalp to help reduce seizures. The study is designed for people with drug-resistant focal epilepsy, which means seizures that haven't been controlled by anti-seizure medications. Researchers want to see if this personalized brain stimulation can decrease how often you have seizures and improve your quality of life.
Many people with epilepsy continue to have seizures even after trying multiple medications, leaving them with few treatment options. This trial explores whether this treatment could offer relief to people whose seizures are not well controlled by drugs alone.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either real brain stimulation or a sham (fake) stimulation first, then switch to the other treatment after a break. Over 10 non-consecutive days, you would come in for two 20-minute sessions each day, with a 20-minute break between them. The researchers will track your seizure frequency, any side effects, and changes in your quality of life throughout the study.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
France